BMPR1B
Bone morphogenetic protein receptor type-1B
Also known as: ALK6, BMR1B_HUMAN, CDw293
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00238
- Gene
- BMPR1B
- Ensembl
- ENSG00000138696
- Chromosome
- 4
- Canonical length
- 502 aa
- Protein class
- CD markers, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are BMPs, which are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. Mutations in this gene have been associated with primary pulmonary hypertension. Several transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Feb 2012]
Canonical amino-acid sequenceUniProt
502 residues, UniProt reviewed canonical sequence.
>O00238|BMPR1B
1 MLLRSAGKLN VGTKKEDGES TAPTPRPKVL RCKCHHHCPE DSVNNICSTD GYCFTMIEED
61 DSGLPVVTSG CLGLEGSDFQ CRDTPIPHQR RSIECCTERN ECNKDLHPTL PPLKNRDFVD
121 GPIHHRALLI SVTVCSLLLV LIILFCYFRY KRQETRPRYS IGLEQDETYI PPGESLRDLI
181 EQSQSSGSGS GLPLLVQRTI AKQIQMVKQI GKGRYGEVWM GKWRGEKVAV KVFFTTEEAS
241 WFRETEIYQT VLMRHENILG FIAADIKGTG SWTQLYLITD YHENGSLYDY LKSTTLDAKS
301 MLKLAYSSVS GLCHLHTEIF STQGKPAIAH RDLKSKNILV KKNGTCCIAD LGLAVKFISD
361 TNEVDIPPNT RVGTKRYMPP EVLDESLNRN HFQSYIMADM YSFGLILWEV ARRCVSGGIV
421 EEYQLPYHDL VPSDPSYEDM REIVCIKKLR PSFPNRWSSD ECLRQMGKLM TECWAHNPAS
481 RLTALRVKKT LAKMSESQDI KLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BMPR1B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- cervix: 23 nTPM
- prostate: 21 nTPM
- seminal vesicle: 13 nTPM
- fallopian tube: 12 nTPM
- basal ganglia: 11 nTPM
- cerebral cortex: 10 nTPM
Single-cell type
- prostatic glandular cells: 2,575 nCPM
- bergmann glia: 1,242 nCPM
- renal collecting duct principal cells: 886 nCPM
- renal collecting duct intercalated cells: 730 nCPM
- astrocytes: 724 nCPM
- respiratory secretory cells: 688 nCPM
Immune cell
- basophil: 0.3 nTPM
- T-reg: 0.2 nTPM
- neutrophil: 0.1 nTPM
- NK-cell: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
- classical monocyte: 0 nTPM
Brain region
- midbrain: 47 nTPM
- medulla oblongata: 46 nTPM
- hypothalamus: 39 nTPM
- thalamus: 39 nTPM
- spinal cord: 38 nTPM
- basal ganglia: 37 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BMPR1B.
Disease | AllUniProt
Conditions BMPR1B is implicated in, by any mechanism.
- Acromesomelic dysplasia 3 (AMD3) MIM:609441
- Brachydactyly A2 (BDA2) MIM:112600
- Brachydactyly A1, D (BDA1D) MIM:616849
Disease | GeneticClinVar
19 pathogenic / likely-pathogenic of 442 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Acromesomelic dysplasia 3
- Type A2 brachydactyly
- Brachydactyly type A1D
- BMPR1B-related disorder
- Acromesomelic dysplasia 2B
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.23
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.27
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- BMP signaling pathway
- cartilage condensation
- cell differentiation
- cellular response to BMP stimulus
- cellular response to growth factor stimulus
- central nervous system neuron differentiation
- chondrocyte development
- dorsal/ventral pattern formation
- endochondral bone morphogenesis
- eye development
- inflammatory response
- MAPK cascade
- negative regulation of chondrocyte proliferation
- osteoblast differentiation
- ovarian cumulus expansion
- ovulation cycle
- positive regulation of bone mineralization
- positive regulation of cartilage development
- positive regulation of chondrocyte differentiation
- positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
- positive regulation of gene expression
- positive regulation of osteoblast differentiation
- positive regulation of transcription by RNA polymerase II
- proteoglycan biosynthetic process
- retina development in camera-type eye
- retinal ganglion cell axon guidance
Molecular functions
- ATP binding
- BMP binding
- BMP receptor activity
- metal ion binding
- protein serine/threonine kinase activity
- SMAD binding
- transforming growth factor beta receptor activity, type I
- transmembrane receptor protein serine/threonine kinase activity
- transmembrane signaling receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ser/Thr protein kinase, TGFB receptor
- Activin types I and II receptor domain
- Protein kinase domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- GS domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- Protein kinase, ATP binding site
- Snake toxin-like superfamily
- Activin types I and II receptor domain
- Protein tyrosine and serine/threonine kinase
- Transforming growth factor beta type I GS-motif
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BMPR1B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BMPR1B as an antibody target. Whether an autoantibody or antibody against BMPR1B could matter depends on whether native BMPR1B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BMPR1B is annotated at the cell surface, where native BMPR1B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label BMPR1B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...